Jason A Keyes Insider Trading $OREX Orexigen Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jason A Keyes.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jason A Keyes. Jason A Keyes is EVP, Chief Financial Officer in Orexigen Therapeutics, Inc. ($OREX) and SVP, Chief Financial Officer in Orexigen Therapeutics, Inc. ($OREX) and Director in Sesen Bio, Inc. ($SESN) and Chief Financial Officer in Equillium, Inc. ($EQ).
Jason A Keyes in Orexigen Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jason A Keyes: EVP, Chief Financial Officer, SVP, Chief Financial Officer
Holdings: 3,031 shares
Current Value: $13,882
Latest Transaction: Oct 17 2017
$OREX Market Capitalization: $70.30M
$OREX Previous Close: $4.58
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Jason A Keyes in Orexigen Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, EQ, OREX, SESN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 17 2017 | OREX | Orexigen Therapeut ... | Keyes Jason A | EVP, Chief Financia ... | Option Exercise | A | 0.00 | 69,600 | 0 | 69,600 | |
| Jun 02 2017 | OREX | Orexigen Therapeut ... | Keyes Jason A | SVP, Chief Financia ... | Grant | A | 1.55 | 557 | 863 | 3,031 | 2.5 K to 3 K (+22.51 %) |
| Feb 07 2017 | OREX | Orexigen Therapeut ... | Keyes Jason A | SVP, Chief Financia ... | Option Exercise | A | 15.00 | 43,500 | 652,500 | 43,500 | |
| Feb 07 2017 | OREX | Orexigen Therapeut ... | Keyes Jason A | SVP, Chief Financia ... | Option Exercise | A | 4.10 | 87,000 | 356,700 | 87,000 | |
| Dec 02 2016 | OREX | Orexigen Therapeut ... | Keyes Jason A | SVP, Chief Financia ... | Grant | A | 1.67 | 291 | 486 | 2,474 | 2.2 K to 2.5 K (+13.33 %) |
| Jul 14 2016 | OREX | Orexigen Therapeut ... | Keyes Jason A | SVP, Chief Financia ... | Option Exercise | A | 15.00 | 15,750 | 236,250 | 15,750 | |
| Jul 14 2016 | OREX | Orexigen Therapeut ... | Keyes Jason A | SVP, Chief Financia ... | Option Exercise | A | 15.00 | 78,750 | 1,181,250 | 78,750 | |
| Jul 14 2016 | OREX | Orexigen Therapeut ... | Keyes Jason A | SVP, Chief Financia ... | Option Exercise | A | 4.02 | 26,250 | 105,525 | 26,250 | |
| Jul 14 2016 | OREX | Orexigen Therapeut ... | Keyes Jason A | SVP, Chief Financia ... | Option Exercise | A | 4.02 | 131,250 | 527,625 | 131,250 |
Page: 1